Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02080507 · ClinicalTrials.gov registry record · NA
rTMS in Treatment Resistant Depression
A NA study of Depression, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT02080507 is a NA study of Depression that has completed, run by Emory University. The registered enrollment target is 12 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02080507, a NA study of Depression, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the safety and efficacy of rTMS as an alternative treatment to ECT. The study will also provide data for a power analysis to support a larger clinical trial if there is evidence of a clinically relevant treatment effect.
Conditions Studied
Interventions
- DEVICE Active Neuronetics rTMS stimulator
- DEVICE Inactive Neuronetics rTMS stimulator
Study Locations (1)
Georgia
- Emory University at Wesley Woods Hospital - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2014-03 |
| Est. Completion | 2015-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02080507
The ClinicalTrials.gov registry entry for NCT02080507 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (98% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Active Neuronetics rTMS stimulator is the first listed.
NCT02080507 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT02080507 about?
NCT02080507 is a clinical study titled "rTMS in Treatment Resistant Depression". The purpose of this study is to determine the safety and efficacy of rTMS as an alternative treatment to ECT. The study will also provide data for a power analysis to support a larger clinical trial if there is evidence of a clinically relevant treatment effect.
What is the current status of trial NCT02080507?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2014-03. Estimated completion is 2015-12.
What conditions does trial NCT02080507 study?
This clinical trial studies the following conditions: Depression.
What interventions are being tested in trial NCT02080507?
The interventions under investigation include: Active Neuronetics rTMS stimulator (DEVICE), Inactive Neuronetics rTMS stimulator (DEVICE).
Who is sponsoring clinical trial NCT02080507?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02080507 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.